GEN Exclusives

More »

Best of the Web

More »
Jul 01, 2009 (Vol. 29, No. 13)
  • Organization, types of documents available
  • Limited number of sources, some documents not translated to English
For research scientists, PubMed is as essential as oxygen—a necessary portal to the publications of others. Yet, probably fewer people are aware of the search portal, which, similar in some respects to PubMed, offers unique advantages and resources of its own. Queries are searched against 24 sources, 18 scientific society sources and 6 government information sources. Abstracts from society documents are free to read, but the article itself must be purchased unless one is a member of that particular society (much like the system employed by PubMed and its various journals). Particularly useful on this site are the other two types of search results: patents and government documents. Complete patents from the U.S., European, and Japanese patent offices are downloadable, although a warning—the Japanese patents are only written in Japanese. The “government documents” category seems only inclusive of the U.S., but perhaps that will change in the future. Across all categories, results can be clustered by subtopic or author. The site is nicely organized, easy to maneuver, and contains pertinent information from a variety of sources.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good

*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Easing Restrictions for Terminal Patients

Should the Federal Government Pass a “Right to Try” Bill Allowing Terminally Ill Patients Access to Experimental Medicines?

More »